-
Research Groups
Clinical Research
-
Nicholson Group
Suellen's group fulfills a dual mission of providing a technically first class, reliable diagnostic, reference and public health service to the healthcare system, and being an innovative, adaptable, forward-looking component of the scientific community and a valued collaborator in research projects, not just in Victoria, but nationally and in the region.
Other work areas include:Hepatitis
Current Projects
-
Estimating HIV incidence in Victoria
As the Victorian State HIV Reference Laboratory, Suellen’s group is involved in a collaborative project with the Department of Infectious Diseases, Alfred Health, Monash University and the Victorian Department of Health and Human Services.
The aims of this study are:
- to assess the HIV incidence in Victoria, annually, between 2012 and 2018
- to determine if there was a decline in incident HIV notifications since the implementation of PrEPX in Victoria in 2016
- to determine if there was a decline in incident HIV notifications among gay and bisexual men and other populations at risk of HIV infection since the implementation of PrEPX in Victoria in 2016.
Lab Team
-
Theo KarapanagiotidisDeputy scientist
-
Vicki StambosWHO Measles/Rubella scientist
-
Bridget FraserBursary student
-
Kim VoBursary student
-
Rianne BrizuelaScientist
-
Josie CamilleriScientist
-
Stavroula CorbyScientist
-
Celia DourosScientist
-
Thomas HolgateScientist
-
Di KaramalakisScientist
-
Theodora KaminisScientist
-
Alma RedzicScientist
-
Kate SharmaScientist
-
Daniel SijmonsScientist
-
Laura StevensScientist
-
Megan TriantafilouScientist
-
Chibo Group
The HIV Characterisation laboratory performs testing to monitor HIV-infected individuals prior to and upon commencement of antiretroviral treatment. Additionally, genotype-assisted antiretroviral resistance testing is available, which identifies the presence of drug resistance mutations so that targeted treatment choices can be made.
-
Kent Group
Stephen’s group studies immunity to HIV and influenza. They are analysing a variety of vaccine strategies, including nanoparticle-based vaccines. They are studying a series of immune responses to gain better insights into protective immunity to important viral pathogens.
Other work areas include:Immunology, Influenza
-
Lewin Group
The main focus of the Lewin group is to understand why HIV infection persists on antiretroviral therapy, to develop new strategies to eliminate latency and to define the biological determinants of immune reconstitution and factors that drive liver disease in HIV-hepatitis B virus co-infection.
Other work areas include:Immunology, Viral Infectious Diseases, COVID-19, Hepatitis
-
Purcell Lab
Professor Damian Purcell’s research group investigates the HIV-1 and HTLV-1 human retroviruses that cause AIDS and leukaemia/inflammatory pathogenesis respectively. The lab studies their genetic structure and gene expression with a focus on defining the mechanisms that control viral persistence and pathogenesis. The molecular interplay of viral and host factors during viral infection and the innate and adaptive immune responses to viral infection are examined. These molecular insights are used to develop new antiviral and curative therapeutics, preventive prophylactic vaccines and passive antibody microbicides and therapeutics. Some of these patented discoveries have been commercialised and we are assisting with clinical trials.
Other work areas include:Host Pathogens Interactions , Immunology, Viral Infectious Diseases, COVID-19
Clinical research in HIV at the Doherty Institute is focused on understanding the barriers to curing HIV infection and developing therapeutic strategies to overcome these. In addition, the Doherty Institute has an active translational research program aimed at understanding how the immune system recovers following treatment of HIV infection and the impact of co-infections that occur commonly in low income countries, including hepatitis B virus (HBV).
Researchers are conducting a range of observational studies understanding where the virus hides on antiviral therapy (ART), and using blood and tissue samples collected from HIV-infected participants they are identifying new drugs that activate or eliminate the virus. Other observational studies are investigating the interaction of HIV and HBV, cytomegalovirus and Cryptococcus, the frequency of HBV drug resistance in HIV-HBV co-infection, and the impact of immune activation on immune function and liver disease following ART. In addition, researchers are leading a range of multi-site local, national and international interventional studies to investigate new interventions that may eliminate persistent virus.
Some of the Doherty Institute’s key collaborators in clinical research activities include the Department of Infectious Diseases at the Alfred Hospital; University of California San Francisco, San Francisco, USA; the Thai Red Cross, Bangkok, Thailand; and the University of Malaya, Kuala Lumpur, Malaysia.
If you are interested in volunteering in the Doherty Institute's clinical trials, please see the projects that are now recruiting volunteers.
Now recruiting volunteers
-
HIV
Do you have HIV and about to undergo immunotherapy for cancer?
Volunteers needed for a study where extra blood tests will be taken during immunotherapy treatment for cancer.
-
HIV
Would you like to help researchers eradicate HIV?
Volunteers needed for a study where large volume of white blood cells are collected to understand where HIV hides on treatment and how to get rid of HIV from its hiding place.
Current projects
-
Hepatitis HIV
A surveillance program for the detection of hepatitis B virus (HBV) resistance to tenofovir (TDF) in HIV-HBV co-infected patient
-
HIV
Circadian HIV RNA Oscillations and Outcomes of Stress (CHRONOS)
-
HIV
Dolutegravir intensification study (DIORR)
-
HIV
Would you like to take part in a study to see where HIV hides in the body?
-
HIV
Imaging the reservoir (iPHOTO3)
-
HIV
Investigating the effects of interferon on HIV persistence in HIV infected patients on ART
-
Hepatitis HIV
Long-term persistence of HIV in the liver and the clinical impact on HIV-HBV co-infection (CHHANEL)
-
HIV
The START HIV-1 Reservoir Sub-study
-
Hepatitis HIV
Towards a Functional cure for HBV: exploiting lessons from HBV-HIV co-infection
-
HIV
Interested in HIV cure research?
Volunteers needed for a clinical trial to test whether high dose vitamin D can reduce HIV that persists despite antiretroviral therapy.
-
